Management of malignant melanoma

Area of Science:

• Oncology
• Dermatology
• Surgical Pathology

Background:

• Malignant melanoma requires precise management strategies.
• Early and accurate diagnosis is crucial for effective treatment.
• Established guidelines are essential for optimal patient outcomes.

Purpose of the Study:

• To outline recommended guidelines for the management of malignant melanoma.
• To provide evidence-based recommendations for diagnostic and therapeutic procedures.
• To inform clinical practice regarding surgical margins, lymph node assessment, and follow-up protocols.

Main Methods:

• Review of diagnostic procedures, including excisional biopsy.
• Analysis of therapeutic excision margins based on Breslow thickness.
• Evaluation of lymph node assessment techniques (sentinel node biopsy vs. elective dissection).
• Assessment of treatment modalities like isolated regional perfusion and radiotherapy.
• Discussion of adjuvant systemic therapy and follow-up strategies.

Main Results:

• Excisional biopsy with specific margins (1-2 cm) is recommended for melanoma.
• Sentinel node biopsy is a valuable tool for detecting lymph node metastases.
• Therapeutic regional lymph node dissection is indicated for confirmed metastases.
• Radiotherapy has palliative and adjuvant roles; adjuvant systemic therapy remains experimental.
• Follow-up duration varies (5-10 years) based on Breslow thickness, with active patient involvement.

Conclusions:

• Current guidelines emphasize tailored surgical approaches and accurate staging for malignant melanoma.
• Sentinel node biopsy offers improved detection of occult metastases.
• Patient education and active participation in follow-up are vital.
• Further research is needed for adjuvant systemic therapies and management of advanced disease.